Diabetic retinopathy in pregnancy

Current Diabetes Reviews

Volumn 5, Issue 3, 2009, Pages 151-156

  Bhatnagar, Ajay ^a   Ghauri, Abdul Jabbar ^a   Hope Ross, Monique ^a,b   Lip, Peck L ^a,b  

^a CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Diabetes mellitus; Diabetic retinopathy; Laser photocoagulation; Pregnancy; Screening

Indexed keywords

AUTACOID; BEVACIZUMAB; C REACTIVE PROTEIN; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; HEMOGLOBIN A1C; INTERLEUKIN 6; RANIBIZUMAB; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; SIGNAL PEPTIDE;

DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; LOW LEVEL LASER THERAPY; MATERNAL CARE; METABOLIC REGULATION; PATHOGENESIS; PATIENT COUNSELING; PATIENT MONITORING; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PRENATAL PERIOD; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINA BLOOD FLOW; REVIEW; RISK FACTOR; SCREENING; VISUAL IMPAIRMENT; FEMALE; METABOLISM; PATHOPHYSIOLOGY; PREGNANCY; RETINA BLOOD VESSEL;

DIABETIC RETINOPATHY; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PREGNANCY; PREGNANCY IN DIABETICS; RETINAL VESSELS; RISK FACTORS;

EID: 70349782496     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339909788920929     Document Type: Review

References (51)

1. Riss B, Riss P. Corneal sensitivity in pregnancy. Ophthalmologica 1981; 183: 57-62.
2. Park SB, Lindahl KJ, Temnycky GO, Aquavella JV. The effect of pregnancy on the corneal curvature. CLAO J 1992; 18: 256-259
3. Weinreb RN, Lu A, Beeson C. Maternal corneal thickness during pregnancy. Am J Ophthalmol 1988; 105: 258-260
4. Akar Y, Yucel I, Akar ME, et al. Effect of pregnancy on intraobserver and intertechnique agreement in intraocular pressure measurements. Ophthalmologica 2005; 219: 36-42. (Pubitemid 40091389)
5. Schultz KL, Birnbaum AD, Goldstein DA. Ocular disease in pregnancy. Curr Opin Ophthalmol 2005; 16: 308-314
6. Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS. Increasing prevalence of gestational diabetes mellitus over time and by birth cohort: Kaiser Permanente of Colorado GDM screening programme. Diabetes Care 2005; 28: 579-584 (Pubitemid 40315316)
7. Lanting LC, Joung IMA, Mackenbach JP, et al. Ethnic differences in mortality, end-stage complications and quality of care among diabetic patients. A Review. Diabetes Care 2005; 28: 2280-2288 (Pubitemid 41242485)
8. Moloney JBM, Drury MJ. The effect of pregnancy on the natural course of diabetic retinopathy. Am J Ophthalmol 1982; 93: 745-756
9. Dibble CM, Kochenour NK, Worley RJ, Tyler FH, Schwartz M. Effect of pregnancy on diabetic retinopathy. Obstet Gynaecol 1982; 59: 699-704.
10. Price JH, Hadden DR, Archer DB, Harley JM. Diabetic retinopathy in pregnancy. Br J Obstet Gynaecol 1984; 91: 11-17
11. Soubrane G, Canivet J, Coscas G. Infuence of pregnancy on the evolution of background retinopathy. Int Ophthalmol 1985; 8: 249-255
12. Phelps RL, Sakol L, Metzger BE, et al. Changes in diabetic retinopathy during pregnancy: correlations with regulation of hyperglycamia. Arch Ophthalmol 1986; 104: 1806-1810
13. Klein BEK, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care 1990; 13: 34-40. (Pubitemid 20024727)
14. Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy: The Diabetes in Early Pregnancy Study. Diabetes Care 1995; 18: 631-637
15. Axer-Siegel R, Hold M, Fink-Cohen S, et al. Diabetic retinopathy during pregnancy. Ophthalmology 1996; 103: 1815-1819
16. The Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the Diabetes Control and Complications Trial. Diabetes Care 2000; 23: 1084-1091
17. Temple RC, Aldridge VA, Sampson MJ, et al. Impact of pregnancy on the progression of diabetic retinopathy in type 1 diabetes. Diabet Med 2001; 18: 573-577 (Pubitemid 32823082)
18. Rahman W, Rahman FZ, Yassin S, et al. Progression of retinopathy during pregnancy in type 1 diabetes mellitus. Clin Exp Ophthalmol 2007; 35(3): 231-236 (Pubitemid 46563480)
19. Thornburg KL, Jacobson S-L, Giraud GD, Morton MJ. Hemodynamic changes in pregnancy. Semin Perinatol 2000; 24: 11-14
20. Chen HC, Newsom RS, Patel V, et al. Retinal blood flow changes during pregnancy in women with diabetes. Invest Ophthalmol Vis Sci 1994; 35: 3199-3208 (Pubitemid 24241358)
21. Schocket LS, Grunwald JE, Tsang AF, DuPont J. The effect of pregnancy on retinal haemodynamics in diabetic versus non-diabetic mothers. Am J Ophthalmol 1999; 128: 477-484
22. Loukovaara S, Harju M, Kaaja R, et al. Retinal capillary blood flow in diabetic and non-diabetic women during pregnancy and postpartum period. Invest Ophthalmol Vis Sci 2003; 44: 1486-1491 (Pubitemid 36378572)
23. Tooke JE. Microvascular function in human diabetes. A physiological perspective. Diabetes 1995; 44: 721-726
24. Simo R, Carrasco E, Garcia Ramirez M, Hernandez C. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev 2006; 2: 71-98. (Pubitemid 44082952)
25. Mitamura Y, Harada C, Harada T. Role of cytokines and trophic factors in the pathogenesis of diabetic retinopathy. Curr Diabetes Rev 2005; 1: 73-81.
26. Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994; 118: 445-450 (Pubitemid 24307211)
27. Andreoli CM, Miller JW. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol 2007; 18: 502-508 (Pubitemid 351339405)
28. Lundbaek K, Christensen NJ, Jensen VA, et al. Diabetic angiopathy and growth hormone. Lancet 1970; 2: 131-133
29. Wilkinson-Berka JL, Wraight C, Werther G. The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy. Curr Med Chem 2006; 13: 3307-3317 (Pubitemid 44669777)
30. Lauszus FF, Klebe JG, Bek T, et al. Increased serum IGF-1 during pregnancy is associated with progression of diabetic retinopathy. Diabetes 2003; 52: 852-856 (Pubitemid 36323596)
31. Lauszus FF. The clinical significance of IGF-1 in maternal serum during pregnancy in type 1 diabetes. Curr Diabetes Rev 2007; 3: 194-197 (Pubitemid 47244064)
32. Ideta R, Yamashita H, Tanaka Y, et al. Role of cytokines in diabetic retinopathy. Arch Ophthalmol 1999; 117: 700-701
33. Loukovaara S, Immonen I, Koistinen R, et al. Inflammatory markers and retinopathy in pregnancies complicated with type I diabetes. Eye 2005; 19: 422-430 (Pubitemid 40553144)
34. Loukovarra S, Immonen IR, Loukavaara MJ, et al. Glycodelin: a novel serum anti-inflammatory marker in type 1 diabetic retinopathy during pregnancy. Acta Ophthalmol Scand 2007; 85: 46-49
35. Lauszus F, Klebe JG, Bek T. Diabetic retinopathy in pregnancy during tight metabolic control. Acta Obstet Gynaecol Scand 2000; 79: 367-370 (Pubitemid 30261143)
36. Bastion ML, Barekh HJ, Muhaya M. Accelerated diabetic retinopathy in pregnancy - a real and present danger. Med J Malaysia 2005; 60: 502-504 (Pubitemid 44152075)
37. Joseph SE, McHugh E, Blott M, et al. Acceleration of diabetic retinopathy in pregnancy: a case report. Diabet Med 2001: 18: 675-678 (Pubitemid 32823068)
38. Chatterjee S, Tsaloumas MD, Geet H, et al. From minimal background diabetic retinopathy to profuse sight threatening vitreoretinal haemorrhage: management issues in a case of pregestational diabetes and pregnancy. Diabet Med 2003; 20: 683-685 (Pubitemid 36966566)
39. Mulholland C, Njoroge T, Mersereau P, et al. Comparison of guidelines available in the United States for diagnosis and management of diabetes before, during and after pregnancy. J Womens Health 2007; 16: 790-801. (Pubitemid 47264827)
40. Sunness JS. The pregnant woman's eye. Surv Ophthalmol 1988; 32: 219-238
41. Rosenn B, Miodovnik M, Kranias G, et al. Progression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy. Am J Obstet Gynecol 1992; 166: 1214-1218
42. Lovestam-Adrian M, Agardh CD, Aberg A, Agardh E. Preeclampsia is a potent risk factor for deterioration of retinopathy during pregnancy in Type 1 diabetic patients. Diabet Med 1997; 14: 1059-1065 (Pubitemid 28015391)
43. CEMACH. Confidential Enquiry into Maternal and Child Health: Pregnancy in Women with Type 1 and Type 2 Diabetes in 2002-2003, England, Wales and Northern Ireland. London: CEMACH 2005.
44. NICE guidelines on diabetes in pregnancy. Management of diabetes and its complications from preconception to the postnatal period. National Institute for Health and Clinical Excellence. http://www.nice.org.uk/nicemedia/pdf/ CG063FullGuidance.pdf
45. Horvat M, Maclean H, Goldbert L, et al. Diabetic retinopathy in pregnancy: a 12-year prospective survey. Br J Ophthalmol 1980; 64: 398-403. (Pubitemid 10056139)
46. Chan WC, Lim LT, Quinn MJ, et al. Management and outcome of sight threatening diabetic retinopathy in pregnancy. Eye 2004; 18: 826-832
47. Sinclair SH, Nesler C, Foxman B, et al. Macular oedema and pregnancy in insulin dependent diabetes. Am J Ophthalmol 1984; 97: 154-167 (Pubitemid 14193161)
48. Halperin LS, Olk RJ, Soubrane G, et al. Safety of fluorescein angiography during pregnancy. Am J Ophthalmol 1990; 109: 563-566
49. Adanis AP, Shima DT. The role of vascular endothelial growth factor in ocular health and disease. Retina 2005; 1: 111-118 (Pubitemid 40365933)
50. Avery RL, Pearlman J, Pieramici J, et al. Intravitreal Bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006; 113: 1695-1705
51. Simo R, Hernandez C. Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy. Diabetologia 2008 [Epub ahead of print].